Short answer · Medically reviewed summary · Last updated: 2026-04-06
Achondroplasia is estimated to affect approximately 1 in 15,000 to 1 in 40,000 live births globally, classifying it as a rare genetic skeletal dysplasia. Epidemiological Overview While the exact prevalence of Achondroplasia is difficult to pinpoint due to variations in reporting, it is widely considered the most common form of disproportionate short stature. The condition occurs due to a mutation in the FGFR3 gene.
What is the prevalence of Achondroplasia?
Prevalence of Achondroplasia: how many people are affected worldwide, differences by sex and region, with sources.
Achondroplasia is estimated to affect approximately 1 in 15,000 to 1 in 40,000 live births globally, classifying it as a rare genetic skeletal dysplasia.
Epidemiological Overview
While the exact prevalence of Achondroplasia is difficult to pinpoint due to variations in reporting, it is widely considered the most common form of disproportionate short stature. The condition occurs due to a mutation in the FGFR3 gene. Regarding gender and ethnicity, Achondroplasia affects males and females equally, and it occurs with similar frequency across all ethnic and geographic populations worldwide. Because it is a congenital condition caused by a genetic mutation, the age of onset is at birth, and individuals live with the diagnosis throughout their entire lifespan.
Challenges in Data Collection
Accurate prevalence data for Achondroplasia remains challenging to capture. While many cases are identified at birth due to characteristic clinical features and radiographic findings, some regions may lack the specialized prenatal or neonatal screening necessary for definitive diagnosis. Furthermore, as the medical community refines diagnostic criteria, we occasionally see shifts in reported incidence rates. It is important to note that the true prevalence may differ from current estimates due to potential underdiagnosis or inconsistent reporting in low-resource settings.
Real-World Perspectives
Medical literature provides the clinical baseline, but community-driven data offers a vital, complementary perspective. Our Achondroplasia community here at DiseaseMaps.org currently includes 36 members who share their lived experiences. These real-world patient reports help us better understand the day-to-day realities of living with Achondroplasia, bridging the gap between cold statistics and the actual human experience of the condition.
Disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Online Mendelian Inheritance in Man (OMIM)
- Little People of America (LPA) Medical Resources
